These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16636128)

  • 1. A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2.
    Morel CF; Thomas MA; Cao H; O'Neil CH; Pickering JG; Foulkes WD; Hegele RA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2689-95. PubMed ID: 16636128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities.
    Vantyghem MC; Pigny P; Maurage CA; Rouaix-Emery N; Stojkovic T; Cuisset JM; Millaire A; Lascols O; Vermersch P; Wemeau JL; Capeau J; Vigouroux C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5337-46. PubMed ID: 15531479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
    Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
    Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
    Patni N; Xing C; Agarwal AK; Garg A
    Am J Med Genet A; 2017 Sep; 173(9):2517-2521. PubMed ID: 28686329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterozygous LMNA mutation p.R471G causes a variable phenotype with features of two types of familial partial lipodystrophy.
    Muschke P; Kölsch U; Jakubiczka S; Wieland I; Brune T; Wieacker P
    Am J Med Genet A; 2007 Dec; 143A(23):2810-4. PubMed ID: 18041775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminopathies and atherosclerosis.
    Al-Shali KZ; Hegele RA
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1591-5. PubMed ID: 15205220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.
    Deng M; Chen W; Qi Y
    Comb Chem High Throughput Screen; 2024; 27(2):346-351. PubMed ID: 37231758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N).
    Kutbay NO; Yurekli BS; Onay H; Altay CT; Atik T; Hekimsoy Z; Saygili F; Akinci B
    Eur J Intern Med; 2016 Apr; 29():37-9. PubMed ID: 26775134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation.
    Jacob KN; Baptista F; dos Santos HG; Oshima J; Agarwal AK; Garg A
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6699-706. PubMed ID: 16174718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Familial partial lipodystrophy (Dunnigan syndrome) due to LMNA gene mutation: The first description of its clinical case in Russia].
    Sorkina EL; Kalashnikova MF; Melnichenko GA; Tyulpakov AN
    Ter Arkh; 2015; 87(3):83-87. PubMed ID: 26027246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A.
    Le Dour C; Schneebeli S; Bakiri F; Darcel F; Jacquemont ML; Maubert MA; Auclair M; Jeziorowska D; Reznik Y; Béréziat V; Capeau J; Lascols O; Vigouroux C
    J Clin Endocrinol Metab; 2011 May; 96(5):E856-62. PubMed ID: 21346069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
    Hegele RA; Cao H; Anderson CM; Hramiak IM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
    Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
    J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.
    Decaudain A; Vantyghem MC; Guerci B; Hécart AC; Auclair M; Reznik Y; Narbonne H; Ducluzeau PH; Donadille B; Lebbé C; Béréziat V; Capeau J; Lascols O; Vigouroux C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4835-44. PubMed ID: 17711925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of lamin A/C to functionally assemble in R482L mutated familial partial lipodystrophy fibroblasts: altered intermolecular interaction with emerin and implications for gene transcription.
    Capanni C; Cenni V; Mattioli E; Sabatelli P; Ognibene A; Columbaro M; Parnaik VK; Wehnert M; Maraldi NM; Squarzoni S; Lattanzi G
    Exp Cell Res; 2003 Nov; 291(1):122-34. PubMed ID: 14597414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial partial lipodystrophy presenting as metabolic syndrome.
    Chan D; McIntyre AD; Hegele RA; Don-Wauchope AC
    J Clin Lipidol; 2016; 10(6):1488-1491. PubMed ID: 27919367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy.
    Motsch I; Kaluarachchi M; Emerson LJ; Brown CA; Brown SC; Dabauvalle MC; Ellis JA
    Eur J Cell Biol; 2005 Sep; 84(9):765-81. PubMed ID: 16218190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type A insulin resistance syndrome revealing a novel lamin A mutation.
    Young J; Morbois-Trabut L; Couzinet B; Lascols O; Dion E; Béréziat V; Fève B; Richard I; Capeau J; Chanson P; Vigouroux C
    Diabetes; 2005 Jun; 54(6):1873-8. PubMed ID: 15919811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype.
    Lombardi F; Gullotta F; Columbaro M; Filareto A; D'Adamo M; Vielle A; Guglielmi V; Nardone AM; Azzolini V; Grosso E; Lattanzi G; D'Apice MR; Masala S; Maraldi NM; Sbraccia P; Novelli G
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4467-71. PubMed ID: 17848409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.